Enlivex Therapeutics Ltd.
NASDAQ:ENLV
1.195 (USD) • At close November 12, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -29.068 | -31.06 | -14.468 | -11.824 | -9.384 | -4.242 | -5.945 | -16.022 | -15.365 | -7.022 | -1.145 | -0.229 |
| Afschrijvingen & Amortisatie
| 0.835 | 0.777 | 0.546 | 0.286 | 0.206 | 0.121 | 0.064 | 0.038 | 0.017 | 0.005 | 0 | 0 |
| Uitgestelde Inkomstenbelasting
| -2.185 | 0 | -5.59 | 0 | 0.119 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 1.951 | 2.712 | 2.914 | 0.67 | 0.81 | 1.009 | 0.408 | 0.7 | 2.623 | 0.736 | 0.254 | 0.009 |
| Verandering in Werkkapitaal
| -1.818 | 0.804 | -1.357 | -0.306 | 1.04 | 0.083 | -0.886 | -0.241 | -0.506 | 1.9 | 0.026 | 0.071 |
| Vorderingen
| 0.608 | 0.278 | -1.249 | 1.823 | 0.041 | -0.13 | 0.567 | 0.399 | -0.786 | -0.245 | 0 | 0 |
| Voorraden
| 0 | -0.278 | 1.249 | -1.823 | -0.041 | 0 | -0.79 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| -1.121 | 1.168 | 0.442 | 0.036 | 0.114 | 0.145 | -0.681 | -0.712 | 0.234 | 2.149 | -0.028 | 0.074 |
| Overig Werkkapitaal
| -1.305 | -0.364 | -1.799 | -0.342 | 0.926 | -0.062 | 0.018 | 0.471 | -0.74 | -0.249 | 0.054 | -0.003 |
| Overige Niet-Contante Posten
| 8.711 | 2.814 | 0.413 | 0.167 | 0.168 | -0.132 | 0.007 | 0.039 | -0.018 | -0.028 | 0.254 | 0 |
| Kasstroom uit Operationele Activiteiten
| -23.523 | -23.953 | -17.542 | -11.007 | -7.041 | -3.161 | -6.352 | -15.486 | -13.249 | -4.409 | -0.865 | -0.149 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -0.236 | -8.122 | -1.625 | -1.019 | -0.193 | -0.461 | -0.002 | -0.018 | -0.048 | -0.063 | -0.002 | 0 |
| Netto Overnames
| 0.133 | -9.705 | -20.03 | 0 | 1.548 | 0 | 0.009 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -26.166 | -1.608 | -104.417 | -19.958 | -7.714 | -0.04 | 0 | 0 | 0 | -22 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0.301 | 72.254 | 67.634 | 0 | -1.548 | 0 | 3 | 9 | 10 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| -0.026 | 9.705 | 20.03 | -0.02 | 1.548 | -0.032 | 3.009 | 9 | 10 | -22 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| -25.968 | 62.524 | -38.408 | -20.977 | -6.359 | -0.533 | 3.007 | 8.982 | 9.952 | -22.063 | -0.002 | 0 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 0.36 | 0.15 | 53.174 | 24.467 | 7.707 | 5.194 | 0 | 6.089 | 0 | 36.785 | 0 | 0.295 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 0 | 0 | 7.808 | 8.615 | 0.599 | 0.005 | 0.008 | 0 | 36.785 | 36.785 | 0.991 | 0.295 |
| Kasstroom uit Financieringsactiviteiten
| 0.36 | 0.15 | 60.982 | 33.082 | 8.306 | 5.194 | 0.008 | 6.089 | 36.785 | 36.785 | 0.991 | 0.295 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.112 | 0 | -0.408 | 0.39 | 0.826 | -0.769 | 0 | 0 | -36.785 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -49.019 | 38.721 | 4.624 | 1.488 | -4.268 | 0.731 | -3.345 | -0.415 | -3.297 | 10.313 | 0.124 | 0.146 |
| Kaspositie aan het Einde van de Periode
| 0.926 | 50.357 | 11.636 | 7.012 | 5.524 | 9.736 | 3.526 | 6.871 | 7.286 | 10.583 | 0.27 | 0.146 |